Kewaunee Scientific Corporation
KEQU
$34.88
$0.320.93%
NASDAQ
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 40.62% | -1.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 40.62% | -1.30% | |||
| Cost of Revenue | 44.29% | -5.83% | |||
| Gross Profit | 31.73% | 11.72% | |||
| SG&A Expenses | 69.46% | -3.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.82% | -5.43% | |||
| Operating Income | -49.26% | 72.19% | |||
| Income Before Tax | -67.57% | 61.77% | |||
| Income Tax Expenses | -111.79% | 377.08% | |||
| Earnings from Continuing Operations | -54.13% | 34.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -314.29% | 84.44% | |||
| Net Income | -54.99% | 37.16% | |||
| EBIT | -49.26% | 72.19% | |||
| EBITDA | -27.23% | 54.57% | |||
| EPS Basic | -54.99% | 36.08% | |||
| Normalized Basic EPS | -68.65% | 64.89% | |||
| EPS Diluted | -55.45% | 36.49% | |||
| Normalized Diluted EPS | -68.88% | 65.85% | |||
| Average Basic Shares Outstanding | 0.00% | 0.81% | |||
| Average Diluted Shares Outstanding | 0.71% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||